Use of copeptin in emergency patients with cardiac chief complaints.

about

Use of copeptin in emergency patients with cardiac chief complaints.

Item

http://www.wikidata.org/entity/Q39442697

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Use of copeptin in emergency patients with cardiac chief complaints.

@en

Use of copeptin in emergency patients with cardiac chief complaints.

@nl

type

Item

label

Use of copeptin in emergency patients with cardiac chief complaints.

@en

Use of copeptin in emergency patients with cardiac chief complaints.

@nl

prefLabel

Use of copeptin in emergency patients with cardiac chief complaints.

@en

Use of copeptin in emergency patients with cardiac chief complaints.

@nl

P1476

Use of copeptin in emergency patients with cardiac chief complaints.

@en

P2093

Anna Slagman

http://www.w3.org/2001/XMLSchema#string

Christian Müller

http://www.w3.org/2001/XMLSchema#string

Joern O Vollert

http://www.w3.org/2001/XMLSchema#string

Julia Searle

http://www.w3.org/2001/XMLSchema#string

Martin Möckel

http://www.w3.org/2001/XMLSchema#string

Martin Stockburger

http://www.w3.org/2001/XMLSchema#string

Reinhold Muller

http://www.w3.org/2001/XMLSchema#string

P2860

Incremental value of copeptin for rapid rule out of acute myocardial infarction.

Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections.

Copeptin improves early diagnosis of acute myocardial infarction.

Additional diagnostic and prognostic value of copeptin ultra-sensitive for diagnosis of non-ST-elevation myocardial infarction in older patients presenting to the emergency department.

Combined determination of highly sensitive troponin T and copeptin for early exclusion of acute myocardial infarction: first experience in an emergency department of a general hospital.

Copeptin: a biomarker of cardiovascular and renal function.

Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study.

Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis.

Copeptin for rapid rule out of acute myocardial infarction in emergency department.

Comparison of contemporary troponin assays with the novel biomarkers, heart fatty acid binding protein and copeptin, for the early confirmation or exclusion of myocardial infarction in patients presenting to the emergency department with chest pain.

P304

393-402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2048872614554197

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25318480

http://www.w3.org/2001/XMLSchema#string